Functional Expression of a Costimulatory B7.2 (CD86) Protein on Human Salivary Gland Epithelial Cells that Interacts with the CD28 Receptor, but Has Reduced Binding to CTLA41

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Immunology

• Publication date

  2001-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.166.5.3107PMID 11207262
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sjögren’s Syndrome or Autoimmune Epithelitis?

  2007cited by this paper
• Soluble CD86 is a costimulatory molecule for human T lymphocytes.

  2000cited by this paper
• Primary Structure and Functional Characterization of a Soluble, Alternatively Spliced Form of B7-11

  2000cited by this paper
• Sjögren's syndrome. Autoimmune epithelitis.

  2000cited by this paper
• Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome.

  1999cited by this paper
• Functional expression of costimulatory molecule CD86 on epithelial cells in the inflamed colonic mucosa.

  1999cited by this paper
• Transplantation of anergic histoincompatible bone marrow allografts.

  1999cited by this paper
• B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha.

  1999cited by this paper
• IL-2-independent activation and proliferation in human T cells induced by CD28.

  1999cited by this paper
• B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

  1999cited by this paper
• The role of B7 co‐stimulation in activation and differentiation ofCD4+and CD8+T cells

  1998cited by this paper
• The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptor.

  1998cited by this paper
• Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions.

  1998cited by this paper
• A Natural Immunological Adjuvant Enhances T Cell Clonal Expansion through a CD28-dependent, Interleukin (IL)-2–independent Mechanism

  1998cited by this paper
• Detection of a soluble form of B7-1 (CD80) in synovial fluid from patients with arthritis using monoclonal antibodies against distinct epitopes of human B7-1.

  1998cited by this paper
• Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4.

  1997cited by this paper
• The CD28‐B7 costimulatory pathway and its role in autoimmune disease

  1997cited by this paper
• Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells: potential role in CD4+ T cell activation during Helicobacter pylori infection.

  1997cited by this paper
• In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferation.

  1997cited by this paper
• CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast Kinetics

  1997cited by this paper
• B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors.

  1997cited by this paper
• The Role of B7‐1/B7‐2:CD28/CLTA‐4 Pathways in the Prevention of Anergy, Induction of Productive Immunity and Down‐Regulation of the Immune Response

  1996cited by this paper
• Costimulation and autoimmunity.

  1996cited by this paper
• Primary porcine endothelial cells express membrane-bound B7-2 (CD86) and a soluble factor that co-stimulate cyclosporin A-resistant and CD28-dependent human T cell proliferation.

  1996cited by this paper
• CTLA-4 ligation blocks CD28-dependent T cell activation [published erratum appears in J Exp Med 1996 Jul 1;184(1):301]

  1996cited by this paper
• CD28/B7 system of T cell costimulation.

  1996cited by this paper
• Porcine endothelial CD86 is a major costimulator of xenogeneic human T cells: cloning, sequencing, and functional expression in human endothelial cells.

  1996cited by this paper
• Activation of CD4+ T lymphocytes form interleukin 2-deficient mice by costimulatory B7 molecules.

  1996cited by this paper
• B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4.

  1995cited by this paper
• CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

  1995cited by this paper
• Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules.

  1995cited by this paper
• Differential expression of alternate mB7-2 transcripts.

  1995cited by this paper
• Potential roles of the B7 and CD28 receptor families in autoimmunity and immune evasion.

  1995cited by this paper
• Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.

  1994cited by this paper
• CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production

  1994cited by this paper
• Sjögren's syndrome: autoimmune epithelitis.

  1994cited by this paper
• Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

  1993cited by this paper
• Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

  1993cited by this paper
• Secretion of alpha-amylase in human parotid gland epithelial cell culture.

  1993cited by this paper
• Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.

  1993cited by this paper
• Functional expression of B7/BB1 on activated T lymphocytes

  1993cited by this paper
• B70 antigen is a second ligand for CTLA-4 and CD28

  1993cited by this paper
• Secretion of α‐amylase in human parotid gland epithelial cell culture

  1993cited by this paper
• Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.

  1992cited by this paper
• Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation

  1991cited by this paper
• CTLA-4 is a second receptor for the B cell activation antigen B7

  1991cited by this paper
• B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.

  1991cited by this paper
• CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.

  1989cited by this paper
• B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells.

  1989cited by this paper
• T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression

  1987cited by this paper

• Potential Relationship Between Helicobacter pylori Infection and Autoimmune Disorders: A Narrative Review.

  2025cites this paper
• A comprehensive review of Sjögren's syndrome: Classification criteria, risk factors, and signaling pathways

  2024cites this paper
• m6A RNA methylation controls salivary gland epithelial cell function and has a protective role in Sjögren’s disease

  2024cites this paper
• The Polysaccharide from Dendrobium officinale Can Improve Mice with Sjögren’s Syndrome by Regulating BAFF and Fas Expressions

  2023cites this paper
• TScan-II: A genome-scale platform for the de novo identification of CD4+ T cell epitopes.

  2023cites this paper
• Salivary dysbiosis in Sjögren’s syndrome and a commensal-mediated immunomodulatory effect of salivary gland epithelial cells

  2021cites this paper
• Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren's syndrome: A review.

  2021cites this paper
• Salivary dysbiosis in Sjögren’s syndrome and a commensal-mediated immunomodulatory effect of salivary gland epithelial cells

  2021cites this paper
• NKp30 Receptor Upregulation in Salivary Glands of Sjögren’s Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment

  2021cites this paper
• Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2

  2021cites this paper
• New frontiers in precision medicine for Sjogren’s syndrome

  2021cites this paper
• Sjögren’s syndrome: a systemic autoimmune disease

  2021cites this paper
• Epithelial–immune cell interplay in primary Sjögren syndrome salivary gland pathogenesis

  2021cites this paper
• Interaction of Human Salivary Gland Epithelial Cells with B Lymphocytes: Implications in the Pathogenesis of Sjögren’s Syndrome

  2020cites this paper
• Immunobiology of T Cells in Sjögren’s Syndrome

  2020cites this paper
• Salivary gland epithelial cells from patients with Sjögren’s syndrome induce B-lymphocyte survival and activation

  2020cites this paper
• B7-H4 Inhibits the Development of Primary Sjögren's Syndrome by Regulating Treg Differentiation in NOD/Ltj Mice

  2020cites this paper
• Autoimmune epithelitis (Sjögren's syndrome); the impact of metabolic status of glandular epithelial cells on auto-immunogenicity.

  2019cites this paper
• Targeting primary Sjögren’s syndrome

  2019influential citation
• Introductory Chapter: Autoimmune Epithelitis - Discussion about Sjögren’s Syndrome and Primary Biliary Cholangitis

  2019cites this paper
• Management of primary Sjögren’s syndrome: recent developments and new classification criteria

  2018cites this paper
• Mitochondrial DNA oxidation induces imbalanced activity of NLRP3/NLRP6 inflammasomes by activation of caspase-8 and BRCC36 in dry eye.

  2017cites this paper
• B7‐H4 deficiency in salivary gland of patients with primary Sjögren's syndrome impairs the regulatory effect on T cells

  2017cites this paper
• Novel Therapeutic Strategies in Primary Sjögren's Syndrome.

  2017cites this paper
• Immune receptors CD40 and CD86 in oral keratinocytes and implications for oral lichen planus.

  2017cites this paper
• Insight into pathogenesis of Sjögren's syndrome: Dissection on autoimmune infiltrates and epithelial cells.

  2017cites this paper
• Immune receptors CD 40 and CD 86 in oral keratinocytes and implications for oral lichen planus

  2017cites this paper
• Novel Therapeutic Strategies in Sjögren’s Syndrome: T-Cell Targeting

  2016cites this paper
• Glandular Epithelium: Innocent Bystander or Leading Actor?

  2016cites this paper
• Primary Sjögren’s syndrome: clinical phenotypes, outcome and the development of biomarkers

  2016cites this paper
• Primary Sjӧgren's syndrome: Clinical phenotypes, outcome and the development of biomarkers.

  2016cites this paper
• Antigen-Presenting Cells and Antigen Presentation in Tertiary Lymphoid Organs

  2016cites this paper
• Dysregulated co-stimulatory molecule expression in a Sjögren's syndrome mouse model with potential implications by microRNA-146a.

  2015influential citation
• Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren's syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathway.

  2015cites this paper
• Mécanismes de la lymphomagenèse au cours des maladies auto-immunes : rôle de la génétique, de l'activité de la maladie et des traitements

  2015cites this paper
• Toll‐like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway

  2014cites this paper
• The complexity of the BAFF forms and their functional implications

  2014cites this paper
• Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome.

  2014cites this paper
• Costimulatory Molecules in Rheumatic Diseases Revisited with an Emphasis on Their Roles in Autoimmune Sjögren’s Syndrome

  2013cites this paper
• Role of salivary gland epithelial cells in the differentiation and activation of T lymphocytes in primary Sjögren's syndrome

  2013influential citation
• GRO-α/CXCR2 System and ADAM17 Correlated Expression in Sjögren’s Syndrome

  2013cites this paper
• Advances in understanding the pathogenesis of primary Sjögren's syndrome

  2013cites this paper
• Treatment of primary Sjögren syndrome

  2012cites this paper
• Local activation and systemic dysregulation of T lymphocytes in Sjögren's syndrome.

  2012cites this paper
• Pathogenesis of Sjögren's syndrome: what we know and what we should learn.

  2012cites this paper
• Clinical significance of sCD 86 levels in patients with acute myelogenous leukemia

  2011cites this paper
• Etiology and Pathogenesis of Sjögren's Syndrome with Special Emphasis on the Salivary Glands

  2011cites this paper
• Pathogenetic Aspects of Primary Sjögren’s Syndrome

  2011cites this paper
• Clinical significance of sCD86 levels in patients with acute myelogenous leukemia

  2011cites this paper
• The role of intrinsic epithelial activation in the pathogenesis of Sjögren's syndrome.

  2010cites this paper
• B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF.

  2010cites this paper
• Regulation of mRNA caspase-8 levels by anti-nuclear autoantibodies

  2010cites this paper
• TNF blocker drugs modulate human TNF-α-converting enzyme pro-domain shedding induced by autoantibodies.

  2010cites this paper
• Effects of biological drug adalimumab on tumour necrosis factor‐α‐converting enzyme activation

  2010cites this paper
• RETRACTED: Blockade of TNF-α signaling suppresses the AREG-mediated IL-6 and IL-8 cytokines secretion induced by anti-Ro/SSA autoantibodies.

  2010cites this paper
• Salivary gland epithelial cells (SGEC): carriers of exquisite B7-2 (CD86) costimulatory molecules.

  2010influential citation
• Current aspects of pathogenesis in Sjögren’s syndrome

  2010cites this paper
• Interferon Type I Driven Immune Activation in Generalized Autoimmune Diseases

  2010cites this paper
• Pro-inflammatory role of Anti-Ro/SSA autoantibodies through the activation of Furin-TACE-amphiregulin axis.

  2010cites this paper
• Induction of TNF-alpha-converting enzyme-ectodomain shedding by pathogenic autoantibodies.

  2009cites this paper
• Tumor Necrosis Factor Inhibitors Block Apoptosis of Human Epithelial Cells of the Salivary Glands

  2009cites this paper
• Fibulin-6 expression and anoikis in human salivary gland epithelial cells: implications in Sjogren's syndrome.

  2009cites this paper
• Ectopic Germinal Centers Are Rare in Sjögren’s Syndrome Salivary Glands and Do Not Exclude Autoreactive B Cells1

  2009cites this paper
• Functional expression of the alpha 2-macroglobulin receptor CD91 in salivary gland epithelial cells.

  2009cites this paper
• Anti‐Ro/SSA autoantibody‐mediated regulation of extracellular matrix fibulins in human epithelial cells of the salivary gland

  2009cites this paper
• Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).

  2009cites this paper
• Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors.

  2008cites this paper
• Neuroendocrine Dysfunction in Sjögren’s Syndrome

  2008cites this paper
• A Novel B7-2 (CD86) Splice Variant with a Putative Negative Regulatory Role1

  2008cites this paper
• The autonomy of different aspects of Sjögren´s syndrome and their treatment in an experimental model: the use of comprehensive biomarker analyses to characterize the disease and the effect of heat-shock proteins in treatment intervention

  2008cites this paper
• This information is current as Putative Negative Regulatory Role A Novel B 7-2 ( CD 86 ) Splice Variant with a and

  2008cites this paper
• T Lymphocytes in Sjögren’s Syndrome: Contributors to and Regulators of Pathophysiology

  2007cites this paper
• Expression of functional Toll‐like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome

  2007cites this paper
• Activation of MKK4 (SEK1), JNK, and c-Jun in labial salivary infiltrating T cells in patients with Sjögren’s syndrome

  2007cites this paper
• Sjögren's Syndrome

  2007cites this paper
• The Role of Epithelial Cells in the Pathogenesis of Sjögren’s Syndrome

  2007cites this paper
• The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: lessons from Sjögren’s syndrome (autoimmune epithelitis)

  2006cites this paper
• B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome

  2006cites this paper
• Salivary gland epithelial cells: a new source of the immunoregulatory hormone adiponectin.

  2006cites this paper
• CHAPTER 31 – Sjögren Syndrome

  2006cites this paper
• Sjögren's syndrome: why autoimmune epithelitis?

  2006cites this paper
• Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome.

  2005cites this paper
• Sjögren's syndrome.

  2005cites this paper
• Salivary gland epithelial cell exosomes: A source of autoantigenic ribonucleoproteins.

  2005cites this paper
• Autoimmunity and Coxsackievirus Infection in Primary Sjögren's Syndrome

  2005cites this paper
• Sjögren's Syndrome and the Lung

  2004cites this paper
• 24 - Sjögren's Syndrome — Autoimmune Epithelitis: Role of Coxsackieviruses in Pathogenesis

  2004cites this paper
• Sjögren ' s syndrome Author : Doctor

  2004cites this paper
• Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome

  2004cites this paper
• Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren’s syndrome

  2003cites this paper
• Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary Sjögren's syndrome.

  2003cites this paper
• The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndrome

  2003cites this paper
• Establishment of a convenient system for the long-term culture and study of non-neoplastic human salivary gland epithelial cells.

  2002cites this paper
• Canine mammary tumor cells transfected with B7-1 or B7-2 stimulate proliferation of peripheral blood mononuclear cells.

  2002cites this paper
• Identifizierung, Klonierung und Charakterisierung von neuen DAP12-assoziierten Rezeptoren exprimiert von myeloiden Zellen

  2002cites this paper
• CD40 on salivary gland epithelial cells: high constitutive expression by cultured cells from Sjögren’s syndrome patients indicating their intrinsic activation

  2002cites this paper
• Sjögren’s Syndrome

  1987cites this paper